Kaposi's sarcoma in sub-Saharan Africa: A current perspective

Current Opinion in Infectious Diseases

Volumn 23, Issue 2, 2010, Pages 119-123

  Mosam, A ^a   Aboobaker, J ^a   Shaik, F ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b SA Columbia Fogarty AITRP   (South Africa)

Author keywords

HIV AIDS; Kaposi's sarcoma; Kaposi's sarcoma herpesvirus; Sub Saharan Africa

Indexed keywords

BLEOMYCIN; DOXORUBICIN; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CLINICAL FEATURE; DISEASE TRANSMISSION; HERPES VIRUS INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; REVIEW; SEROPREVALENCE; SEXUAL TRANSMISSION; SOUTH AFRICA; UGANDA;

AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES;

EID: 77649245313     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328335b01a     Document Type: Review

References (24)

1. http://www.unaids.org. [Accessed 24 March 2009]
2. Parkin DM, Sitas F, Chitenge M, et al. Cancer in indigenous Africans: burden, distribution and trends. Lancet Oncology 2008; 9:683-692.
3. Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 2003; 88:1-3.
4. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AID-associated Kaposi's sarcoma. Science 1994; 226:1865-1869.
5. Minhas V, Crabtree KL, Chao A, et al. Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. Am J Epidemiol 2008; 168:311-320.
6. Butler LM, Dorsey G, Hladik W, et al. Kaposi's sarcoma-associated herpes virus seroprevalence in population-based samples of African children: evidence for at least two patterns of KSHV transmission. J Infect Dis 2009; 200:430-438.
7. Malope BI, MacPhail P, Mbisa G, et al. No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS 2008; 22:519-526.
8. Kasolo FC, Spinks J, Bima H, et al. Diverse genotypes of Kaposi's sarcoma associated herpesvirus (KSHV) identified in infant blood infections in African childhood-KS and HIV/AIDS endemic region. J Med Virol 2007; 79:1555-1561.
9. White T, Hagen M, Gudza I, et al. Genetic diversity of the Kaposi's sarcoma herpesvirus K1 protein in AIDS-KS in Zimbabwe. J Clin Virol 2008; 42:165-171.
10. Johnston C, Orem J, Okuku F, et al. Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. PLoS One 2009; 4:e4222.
11. Stein L, Urban MI, O'Connell D, et al. The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer 2008; 122:2260-2265.
12. Mosam A, Carrara H, ShaikF, et al. Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983 to 2006). Int J STD AIDS 2009; 20:553-556.
13. Asuquo ME, Ngim O, Ugare G, et al. Major dermatologic malignancies encountered in a teaching hospital surgical department in South Nigeria. Am J Clin Dermatol 2008; 9:383-387.
14. Butt FM, Chindia ML, Rana F, Machigo FG. Pattern of head and neckmalignant neoplasms in HIV-infected patients in Kenya. Int J Oral Maxillofac Surg 2008; 37:907-911.
15. Mosam A, Hurkchand HP, Cassol E, et al. Characteristics of HIV-1-associated Kaposi's sarcoma among women and men in South Africa. Int J STD AIDS 2008; 19:400-405.
16. Pitche PT, Kombate K, Owono F, Tchangai-Walla K. Kaposi's sarcoma in a hospital setting in Lome (Togo): a study of 93 cases. Int J Dermatol 2007; 46 (Suppl 1):42-44. (Pubitemid 47534890)
17. Theron S, Andronikou S, George R, et al. Noninfective pulmonary disease in HIV-positive children. Pediatr Radiol 2009; 39:555-564.
18. Mosam A, Uldrick T, Shaik F, et al. Availability of highly active antiretroviral therapy improves the ability to treat Kaposi's sarcoma in South Africa. Int J STD and AIDS (in press).
19. Makombe SD, Harries AD, Yu JK, et al. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Trop Doct 2008; 38:5-7.
20. Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008; 22:601-610.
21. Letang E, Almeida J, Ayala E, et al. Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in Mozambique: a prospective study. J Acquir Immune Defic Syndr 2009 [Epub ahead of print].
22. Singh NB, Lakier RH, Donde B. Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma: a prospective randomized trial. Radiother Oncol 2008; 88:211-216.
23. Mlombe Y. Management of HIV associated Kaposi's sarcoma in Malawi. Malawi Med J 2008; 20:129-132.
24. Bihl F, Mosam A, Henry LM, et al. KSHV-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C infected individuals presenting with Kaposi's sarcoma. AIDS 2007; 21:1245-1252.